GSK · SUB~ · EC · HOSPITAL SAN FRANCISCO DE QUITO

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «HOSPITAL SAN FRANCISCO DE QUITO», 13,722 USD (≈ $13,722); method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁL; OCID ocds-5wno2w-CE-20240002565442-390394, ocds-5wno2w-CE-20240002565443-390394; ↓ weak method (catalogue / exclusivity / accreditation / small purchase).

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject

GSK · SUB~ · EC · HOSPITAL SAN FRANCISCO DE QUITO

Indicator

Debarred / sanctioned abroad × US SEC issuer

Amount

13,722

Records behind the indicator

2

Found

4 October 2026

Code

W-02859

Reference

SICM-366-2022-A

Reference

ocds-5wno2w-CE-20240002565442-390394

Reference

ocds-5wno2w-CE-20240002565443-390394